- Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients
-
Kim YJ, Kim K, Hwang SH, Kim SS, Lee D, Cheong JY, Cho SW
- KMID: 1705208
- Clin Mol Hepatol.
- 2013 Sep;19(3):300-304.
- doi: 10.3350/cmh.2013.19.3.300
BACKGROUND/AIMS: Relapse has been reported after stopping nucleos(t)ide (NUC) therapy in the majority of chronic HBeAg negative hepatitis patients. However, the ideal treatment duration of HBeAg negative chronic hepatitis B... -
- CITED
-
- Close
- SHARE
-
- Close
